✦ LIBER ✦

First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice

✍ Scribed by S. Pol; P. Lampertico

Book ID: 115076251
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 139 KB
Volume: 19
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2012.01602.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1807 Long-Term Outcome of Chronic Hepat

W1807 Long-Term Outcome of Chronic Hepatitis B Patients Initially Treated with Entecavir in a Real-Life Clinical Setting

✍ Ha, Nghiem B.; Ha, Nghi B.; Garcia, Ruel T.; Trinh, Huy N.; Vu, Andrew A.; Nguye 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

Randomized, observational study of long-

Randomized, observational study of long-term entecavir treatment versus other standard of care nucleos (t) ide analog therapy in nucleos(t)ide-naïve patients with chronic hepatitis B from a ‘real-world’ clinical practice setting in china

✍ Hou, Jin-Lin; Jia, Ji-Dong; Wei, Lai; Ren, Hong; Xie, Ji-Dong; Gao, Lai; Zhao, H 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 95 KB

M1903 Long-Term Outcome of Treatment-Naï

M1903 Long-Term Outcome of Treatment-NaïVE Chronic Hepatitis B (CHB) E Antigen-Negative Treated With Entecavir 0.5 Mg (ETV) or Adefovir 10 Mg (ADV) in a Real-Life Community Setting

✍ Ha, Nghiem B.; Ha, Nghi B.; Garcia, Ruel T.; Trinh, Huy N.; Nguyen, Huy A.; Nguy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB